Nattokinase: Blood Pressure Trials, Clot Claims and Safety
Small nattokinase BP trials have commercial ties and a pooling concern. Laboratory clot degradation and human blood-marker findings do not establish Long COVID recovery or patient microclot clearance; bleeding, medicines and product composition need careful review.